LivaNova PLC
LIVN
Peringkat dalam Saham
#3842
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
Harga Saham
$78.37
Terakhir disinkronkan: 2026-10-19
Kapitalisasi Pasar
$4.31B
Perubahan (1 hari)
1.02%
Perubahan (1 tahun)
44.86%
Negara
GB
Perdagangan LivaNova PLC (LIVN)
Kategori
Healthcare
EPS untuk LivaNova PLC (LIVN)
EPS per June 2026 TTM: $3.45
Menurut laporan keuangan terbaru dan harga saham LivaNova PLC, EPS perusahaan saat ini (TTM) adalah $3.45. Pada akhir 2023, perusahaan memiliki EPS sebesar $0.33 peningkatan dibandingkan EPS tahun 2022 sebesar $-1.61.
Riwayat EPS untuk LivaNova PLC dari 2000 hingga 2026
EPS di akhir setiap tahun
| Tahun | EPS | Mengubah |
|---|---|---|
| 2026 (TTM) | $3.45 | 194.87% |
| 2024 | $1.17 | 254.55% |
| 2023 | $0.33 | -120.50% |
| 2022 | $-1.61 | -39.93% |
| 2021 | $-2.68 | -62.04% |
| 2020 | $-7.06 | 119.25% |
| 2019 | $-3.22 | -17.65% |
| 2018 | $-3.91 | 651.92% |
| 2017 | $-0.52 | -59.69% |
| 2016 | $-1.29 | -158.90% |
| 2015 | $2.19 | 8.42% |
| 2014 | $2.02 | 20.24% |
| 2013 | $1.68 | 29.23% |
| 2012 | $1.30 | -22.16% |
| 2011 | $1.67 | -40.99% |
| 2010 | $2.83 | 183.00% |
| 2009 | $1.00 | -356.41% |
| 2008 | $-0.39 | -80.60% |
| 2007 | $-2.01 | -15.19% |
| 2006 | $-2.37 | 364.71% |
| 2005 | $-0.51 | -275.86% |
| 2004 | $0.29 | 20.83% |
| 2003 | $0.24 | -119.83% |
| 2002 | $-1.21 | 611.76% |
| 2000 | $-0.17 | 0.00% |
EPS untuk perusahaan sejenis atau pesaing
| Perusahaan | EPS | Perbedaan EPS | Negara |
|---|---|---|---|
| $3.11 | -9.86% |
US
|
|
| $3.59 | 4.06% |
IE
|
|
| $9.73 | 182.03% |
US
|
|
| $2.48 | -28.12% |
US
|
|
| - | - |
DE
|
